Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Hemasphere|March 25, 2025
Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed-methods, prospective cohort studyElisabeth Dovern, Sterre J A M Nijland, Annemarie M J Braamse, et al.
Science Translational Medicine|August 18, 2020
Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipientsYannouck F van Lier, Mark Davids, Nienke J E Haverkate, et al.
British Journal of Haematology|August 11, 2023
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioningMesire Aydin, David C de Leeuw, Caroline E Rutten, et al.
Transfusion|August 2, 2022
Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approachJorn J Gerritsma, Nieke van der Bolt, Robin van Bruggen, et al.
Transplantation and Cellular Therapy|October 24, 2022
Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional StudyYannouck F van Lier, Thierry Rolling, Gabriel K Armijo, et al.
American Journal of Hematology|May 11, 2024
Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort studyElisabeth Dovern, Mesire Aydin, Mette D Hazenberg, et al.
Experimental Hematology|June 23, 2009
Elevated endothelial progenitor cells during painful sickle cell crisisRachel T van Beem, Erfan Nur, Jaap Jan Zwaginga, et al.
Haematologica|February 26, 2026
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label studyGeoffrey Z L Kuppens, Maria Armila D Ruiz, Myrthe J Van Dijk, et al.
American Journal of Hematology|September 27, 2008
Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertensionEduard J van Beers, Erfan Nur, Cornelia M Schaefer-Prokop, et al.
Hemasphere|December 12, 2024
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trialAnnoek E C Broers, Ellen Meijer, Bronno van der Holt, et al.
Pageof 8